A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsSreenath V. Sharma, Jeff Settleman, Diana Lee et al.|Cell|2010Cited by 2.8k
Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett, Daniel A. Haber, Ah Ting Tam et al.|Nature|2012Cited by 2.6k
Oncogene addiction: setting the stage for molecularly targeted cancer therapySreenath V. Sharma, Jeffrey Settleman|Genes & Development|2007Cited by 445
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingUltan McDermott, Jeffrey Settleman, Sreenath V. Sharma et al.|Proceedings of the National Academy of Sciences|2007Cited by 358
Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Rachel Y. Ames et al.|Cancer Research|2009Cited by 98